Business Opportunities and Investment Strategies for Global Recombinant Cell Culture Supplements Market 2023-2033

PrintEmail
May 2024 | 224 Pages | From $1,000
Description

The report cover may be different from the image shown.

  • The product will be delivered as a PDF file by Email within 48 business hours upon receiving an order. 
  • To learn more about the report, please Download General Sample Pages and Download Excel Datasheet SampleThe report will be updated before delivery, so that the most recent historic year is the base year and forecast covers 5-10 years over the base year.
  • Price of regional full report = price of global full report - $1,000.
  • Price of national full report = price of global full report - $1,800.
  • Price of tables/figures = $50 each.
  • Please Contact Us for any question, custom research, and current discount. It is possible now to buy a part of the report such as chapters, sections, data tables or figures.
  • For details about the license types, please refer to our Terms of Service 
Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

 

Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global recombinant cell culture supplements market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.

Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the recombinant cell culture supplements industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global recombinant cell culture supplements industry.

Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global recombinant cell culture supplements market is expected to reach $1.42 billion by 2033, growing by 10.5% annually over the coming years.

Segmentation Analysis
Highlighted with 91 tables and 108 figures, this 224-page report represents a 360-degree view on the global market with extensively detailed segmentations by Product, Source, Expression System, Application, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.

By Product
• Recombinant Albumin (rAlbumin)
• Recombinant Insulin (rInsulin)
• Recombinant Epidermal Growth Factor (rEGF)
• Recombinant Interleukin Growth Factor (rILGF)
• Recombinant Transferrin (rTransferrin)
• Recombinant Trypsin (rTrypsin)
• Recombinant Insulin-like Growth Factor (rIGF)
• Recombinant Stem Cell Factor (rSCF)
• Recombinant Aprotinin (rAprotinin)
• Recombinant Lysozyme (rLysozyme)
• Other Products

By Source
• Animals
• Human
• Microorganisms

By Expression System
• Mammalian
• E. Coli
• Yeast
• Other Expression Systems

By Application
• Stem Cell and Regenerative Medicine
o Stem Cell Therapies
o Cell Therapies
o Gene Therapies and Others
• Bio-Production
o Monoclonal Antibodies
o Recombinant Proteins
o Hormones
o Vaccines
o Other Biological Products
• Academic Research

By End User
• Biopharmaceutical Companies
• Contract Research Centers (CROs)
• Academic & Research Institutes

By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Product, Expression System, and Application over the forecast years are also included.

Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• Abcam plc.
• BBI Solutions OEM Limited
• Becton, Dickinson and Company
• Cell Sciences, Inc.
• Corning Incorporated
• F. Hoffmann-La Roche Ltd.
• FUJIFILM Irvine Scientific, Inc.
• Gemini Bioproducts, LLC
• HiMedia Laboratories, LLC
• InVitria
• Kingfisher Biotech, Inc.
• Lonza Group AG
• Merck KGaA
• Novus Biologicals, LLC
• R&D Systems, Inc.
• Sartorius AG
• Sino Biological Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.

Reasons to Purchase
• Gain a most comprehensive view on global market with lighting on market outlook, segmentations, dynamics and trends, growth opportunities, risk assessment, critical success factors (CSFs), increasingly attractive segments (IAS), and Porter’s Fiver Forces analysis.
• Access identified business opportunities and benchmarked investment strategies.
• Obtain up-to-date data and valuable insights to create regional and national strategies.
• Take wise actions to mitigate potential risk based on the matrix of systematic risk evaluation.
• Outperform competitors using the latest market data and research discoveries.
• Support internal and external presentations with reliable data and profound analysis.
• Backed up by premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
• Supported by free customer services before and after sales.

Table of Contents

1 Introduction 12
1.1 Industry Definition and Research Scope 12
1.1.1 Industry Definition 12
1.1.2 Research Scope 13
1.2 Research Methodology 16
1.2.1 Overview of Market Research Methodology 16
1.2.2 Market Assumption 17
1.2.3 Secondary Data 17
1.2.4 Primary Data 17
1.2.5 Data Filtration and Model Design 18
1.2.6 Market Size/Share Estimation 19
1.2.7 Research Limitations 20
1.3 Executive Summary 21
2 Market Overview and Dynamics 24
2.1 Market Size and Forecast 24
2.1.1 Impact of COVID-19 on World Economy 25
2.1.2 Impact of COVID-19 on the Market 29
2.1.3 Impact of Russia-Ukraine Conflict 31
2.1.4 Impact of Israel-Palestine War 33
2.2 Major Growth Drivers 34
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porter’s Fiver Forces Analysis 45
3 Segmentation of Global Market by Product 49
3.1 Market Overview by Product 49
3.2 Recombinant Albumin (rAlbumin) 52
3.3 Recombinant Insulin (rInsulin) 53
3.4 Recombinant Epidermal Growth Factor (rEGF) 54
3.5 Recombinant Interleukin Growth Factor (rILGF) 55
3.6 Recombinant Transferrin (rTransferrin) 56
3.7 Recombinant Trypsin (rTrypsin) 57
3.8 Recombinant Insulin-like Growth Factor (rIGF) 58
3.9 Recombinant Stem Cell Factor (rSCF) 59
3.10 Recombinant Aprotinin (rAprotinin) 60
3.11 Recombinant Lysozyme (rLysozyme) 61
3.12 Other Products 62
4 Segmentation of Global Market by Source 63
4.1 Market Overview by Source 63
4.2 Animals 66
4.3 Human 67
4.4 Microorganisms 68
5 Segmentation of Global Market by Expression System 69
5.1 Market Overview by Expression System 69
5.2 Mammalian 72
5.3 E. Coli 73
5.4 Yeast 74
5.5 Other Expression Systems 75
6 Segmentation of Global Market by Application 76
6.1 Market Overview by Application 76
6.2 Stem Cell and Regenerative Medicine 79
6.2.1 Stem Cell Therapies 80
6.2.2 Cell Therapies 81
6.2.3 Gene Therapies and Others 82
6.3 Bio-Production 83
6.3.1 Monoclonal Antibodies 85
6.3.2 Recombinant Proteins 86
6.3.3 Hormones 87
6.3.4 Vaccines 88
6.3.5 Other Biological Products 89
6.4 Academic Research 90
7 Segmentation of Global Market by End User 91
7.1 Market Overview by End User 91
7.2 Biopharmaceutical Companies 94
7.3 Contract Research Centers (CROs) 95
7.4 Academic & Research Institutes 96
8 Segmentation of Global Market by Region 97
8.1 Geographic Market Overview 2023-2033 97
8.2 North America Market 2023-2033 by Country 102
8.2.1 Overview of North America Market 102
8.2.2 U.S. 106
8.2.3 Canada 110
8.2.4 Mexico 113
8.3 European Market 2023-2033 by Country 116
8.3.1 Overview of European Market 116
8.3.2 Germany 120
8.3.3 U.K. 123
8.3.4 France 126
8.3.5 Spain 129
8.3.6 Italy 132
8.3.7 Russia 135
8.3.8 Rest of European Market 138
8.4 Asia-Pacific Market 2023-2033 by Country 140
8.4.1 Overview of Asia-Pacific Market 140
8.4.2 Japan 144
8.4.3 China 148
8.4.4 Australia 151
8.4.5 India 154
8.4.6 South Korea 157
8.4.7 Rest of APAC Region 160
8.5 South America Market 2023-2033 by Country 162
8.5.1 Argentina 166
8.5.2 Brazil 169
8.5.3 Chile 172
8.5.4 Rest of South America Market 175
8.6 MEA Market 2023-2033 by Country 176
8.6.1 UAE 180
8.6.2 Saudi Arabia 183
8.6.3 South Africa 186
8.6.4 Other National Markets 189
9 Competitive Landscape 190
9.1 Overview of Key Vendors 190
9.2 New Product Launch, Partnership, Investment, and M&A 193
9.3 Company Profiles 194
Abcam plc. 194
BBI Solutions OEM Limited 196
Becton, Dickinson and Company 197
Cell Sciences, Inc. 198
Corning Incorporated 199
F. Hoffmann-La Roche Ltd. 200
FUJIFILM Irvine Scientific, Inc. 201
Gemini Bioproducts, LLC 202
HiMedia Laboratories, LLC 203
InVitria 204
Kingfisher Biotech, Inc. 205
Lonza Group AG 206
Merck KGaA 207
Novus Biologicals, LLC 208
R&D Systems, Inc. 209
Sartorius AG 210
Sino Biological Inc. 211
STEMCELL Technologies Inc. 212
Thermo Fisher Scientific Inc. 213
10 Investing in Recombinant Cell Culture Supplements Industry: Risk Assessment and Management 214
10.1 Risk Evaluation of Global Market 214
10.2 Critical Success Factors (CSFs) 221
RELATED REPORTS 224

List of Tables:

Table 1. Snapshot of Global Recombinant Cell Culture Supplements Market in Balanced Perspective, 2023-2033 22
Table 2. World Economic Outlook, 2024-2036 26
Table 3. World Economic Outlook, 2022-2024 28
Table 4. Scenarios for Economic Impact of Ukraine Crisis 32
Table 5. Scenarios for Economic Impact of Israel-Palestine War 33
Table 6. Estimated Worldwide Spending on Biopharmaceutical R&D, 2015-2023, $ billion 37
Table 7. World Health Spending by Region, $ bn, 2013-2020 38
Table 8. Main Product Trends and Market Opportunities in Global Recombinant Cell Culture Supplements Market 42
Table 9. Global Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 50
Table 10. Global Recombinant Cell Culture Supplements Market by Source, 2023-2033, $ mn 64
Table 11. Global Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 70
Table 12. Global Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 77
Table 13. Global Recombinant Cell Culture Supplements Market: Stem Cell and Regenerative Medicine by Type, 2023-2033, $ mn 79
Table 14. Global Recombinant Cell Culture Supplements Market: Bio-Production by Type, 2023-2033, $ mn 84
Table 15. Global Recombinant Cell Culture Supplements Market by End User, 2023-2033, $ mn 92
Table 16. Global Recombinant Cell Culture Supplements Market by Region, 2023-2033, $ mn 99
Table 17. Leading National Recombinant Cell Culture Supplements Market, 2023 and 2033, $ mn 101
Table 18. North America Recombinant Cell Culture Supplements Market by Country, 2023-2033, $ mn 104
Table 19. U.S. Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 108
Table 20. U.S. Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 109
Table 21. U.S. Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 109
Table 22. Canada Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 111
Table 23. Canada Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 112
Table 24. Canada Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 112
Table 25. Mexico Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 114
Table 26. Mexico Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 115
Table 27. Mexico Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 115
Table 28. Europe Recombinant Cell Culture Supplements Market by Country, 2023-2033, $ mn 118
Table 29. Germany Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 121
Table 30. Germany Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 122
Table 31. Germany Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 122
Table 32. U.K. Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 124
Table 33. U.K. Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 125
Table 34. U.K. Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 125
Table 35. France Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 127
Table 36. France Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 128
Table 37. France Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 128
Table 38. Spain Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 130
Table 39. Spain Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 131
Table 40. Spain Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 131
Table 41. Italy Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 133
Table 42. Italy Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 134
Table 43. Italy Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 134
Table 44. Russia Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 136
Table 45. Russia Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 137
Table 46. Russia Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 137
Table 47. Recombinant Cell Culture Supplements Market in Rest of Europe by Country, 2023-2033, $ mn 139
Table 48. APAC Recombinant Cell Culture Supplements Market by Country, 2023-2033, $ mn 142
Table 49. Japan Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 146
Table 50. Japan Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 147
Table 51. Japan Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 147
Table 52. China Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 149
Table 53. China Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 150
Table 54. China Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 150
Table 55. Australia Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 152
Table 56. Australia Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 153
Table 57. Australia Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 153
Table 58. India Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 155
Table 59. India Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 156
Table 60. India Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 156
Table 61. South Korea Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 158
Table 62. South Korea Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 159
Table 63. South Korea Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 159
Table 64. Recombinant Cell Culture Supplements Market in Rest of APAC by Country/Region, 2023-2033, $ mn 161
Table 65. South America Recombinant Cell Culture Supplements Market by Country, 2023-2033, $ mn 164
Table 66. Argentina Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 167
Table 67. Argentina Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 168
Table 68. Argentina Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 168
Table 69. Brazil Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 170
Table 70. Brazil Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 171
Table 71. Brazil Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 171
Table 72. Chile Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 173
Table 73. Chile Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 174
Table 74. Chile Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 174
Table 75. MEA Recombinant Cell Culture Supplements Market by Country, 2023-2033, $ mn 178
Table 76. UAE Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 181
Table 77. UAE Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 182
Table 78. UAE Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 182
Table 79. Saudi Arabia Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 184
Table 80. Saudi Arabia Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 185
Table 81. Saudi Arabia Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 185
Table 82. South Africa Recombinant Cell Culture Supplements Market by Product, 2023-2033, $ mn 187
Table 83. South Africa Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, $ mn 188
Table 84. South Africa Recombinant Cell Culture Supplements Market by Application, 2023-2033, $ mn 188
Table 85. Abcam plc.: Company Snapshot 194
Table 86. Abcam plc.: Business Segmentation 195
Table 87. Abcam plc.: Product Portfolio 195
Table 88. List of Risk Factors and Weight Percentages/Theoretical Maximum 215
Table 89. Definition of GMD Relative Risk Index Number (Relative RIN) and GMD Risk Intensity Level (RIL) 217
Table 90. Risk Evaluation for Investing in Global Market, 2023-2033 218
Table 91. Critical Success Factors and Key Takeaways 222

List of Figures:

Figure 1. Research Method Flow Chart 16
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 19
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033 21
Figure 4. Global Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 24
Figure 5. Impact of COVID-19 on Business 29
Figure 6. Primary Drivers and Impact Factors of Global Recombinant Cell Culture Supplements Market 34
Figure 7. World Population 65 and Over, % of Total Population, 1950-2060 37
Figure 8. Primary Restraints and Impact Factors of Global Recombinant Cell Culture Supplements Market 39
Figure 9. Porter’s Fiver Forces Analysis of Global Recombinant Cell Culture Supplements Market 45
Figure 10. Growth Opportunity Analysis by Product 49
Figure 11. Breakdown of Global Recombinant Cell Culture Supplements Market by Product, 2023-2033, % of Revenue 50
Figure 12. Global Addressable Market Cap in 2024-2033 by Product, Value ($ mn) and Share (%) 51
Figure 13. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Albumin (rAlbumin), 2023-2033, $ mn 52
Figure 14. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Insulin (rInsulin), 2023-2033, $ mn 53
Figure 15. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Epidermal Growth Factor (rEGF), 2023-2033, $ mn 54
Figure 16. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Interleukin Growth Factor (rILGF), 2023-2033, $ mn 55
Figure 17. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Transferrin (rTransferrin), 2023-2033, $ mn 56
Figure 18. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Trypsin (rTrypsin), 2023-2033, $ mn 57
Figure 19. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Insulin-like Growth Factor (rIGF), 2023-2033, $ mn 58
Figure 20. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Stem Cell Factor (rSCF), 2023-2033, $ mn 59
Figure 21. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Aprotinin (rAprotinin), 2023-2033, $ mn 60
Figure 22. Global Recombinant Cell Culture Supplements Market by Product: Recombinant Lysozyme (rLysozyme), 2023-2033, $ mn 61
Figure 23. Global Recombinant Cell Culture Supplements Market by Product: Other Products, 2023-2033, $ mn 62
Figure 24. Growth Opportunity Analysis by Source 63
Figure 25. Breakdown of Global Recombinant Cell Culture Supplements Market by Source, 2023-2033, % of Sales Revenue 64
Figure 26. Global Addressable Market Cap in 2024-2033 by Source, Value ($ mn) and Share (%) 65
Figure 27. Global Recombinant Cell Culture Supplements Market by Source: Animals, 2023-2033, $ mn 66
Figure 28. Global Recombinant Cell Culture Supplements Market by Source: Human, 2023-2033, $ mn 67
Figure 29. Global Recombinant Cell Culture Supplements Market by Source: Microorganisms, 2023-2033, $ mn 68
Figure 30. Growth Opportunity Analysis by Expression System 69
Figure 31. Breakdown of Global Recombinant Cell Culture Supplements Market by Expression System, 2023-2033, % of Sales Revenue 70
Figure 32. Global Addressable Market Cap in 2024-2033 by Expression System, Value ($ mn) and Share (%) 71
Figure 33. Global Recombinant Cell Culture Supplements Market by Expression System: Mammalian, 2023-2033, $ mn 72
Figure 34. Global Recombinant Cell Culture Supplements Market by Expression System: E. Coli, 2023-2033, $ mn 73
Figure 35. Global Recombinant Cell Culture Supplements Market by Expression System: Yeast, 2023-2033, $ mn 74
Figure 36. Global Recombinant Cell Culture Supplements Market by Expression System: Other Expression Systems, 2023-2033, $ mn 75
Figure 37. Growth Opportunity Analysis by Application 76
Figure 38. Breakdown of Global Recombinant Cell Culture Supplements Market by Application, 2023-2033, % of Revenue 77
Figure 39. Global Addressable Market Cap in 2024-2033 by Application, Value ($ mn) and Share (%) 78
Figure 40. Global Recombinant Cell Culture Supplements Market by Application: Stem Cell and Regenerative Medicine, 2023-2033, $ mn 79
Figure 41. Global Recombinant Cell Culture Supplements Market by Stem Cell and Regenerative Medicine: Stem Cell Therapies, 2023-2033, $ mn 80
Figure 42. Global Recombinant Cell Culture Supplements Market by Stem Cell and Regenerative Medicine: Cell Therapies, 2023-2033, $ mn 81
Figure 43. Global Recombinant Cell Culture Supplements Market by Stem Cell and Regenerative Medicine: Gene Therapies and Others, 2023-2033, $ mn 82
Figure 44. Global Recombinant Cell Culture Supplements Market by Application: Bio-Production, 2023-2033, $ mn 83
Figure 45. Global Recombinant Cell Culture Supplements Market by Bio-Production: Monoclonal Antibodies, 2023-2033, $ mn 85
Figure 46. Global Recombinant Cell Culture Supplements Market by Bio-Production: Recombinant Proteins, 2023-2033, $ mn 86
Figure 47. Global Recombinant Cell Culture Supplements Market by Bio-Production: Hormones, 2023-2033, $ mn 87
Figure 48. Global Recombinant Cell Culture Supplements Market by Bio-Production: Vaccines, 2023-2033, $ mn 88
Figure 49. Global Recombinant Cell Culture Supplements Market by Bio-Production: Other Biological Products, 2023-2033, $ mn 89
Figure 50. Global Recombinant Cell Culture Supplements Market by Application: Academic Research, 2023-2033, $ mn 90
Figure 51. Growth Opportunity Analysis by End User 91
Figure 52. Breakdown of Global Recombinant Cell Culture Supplements Market by End User, 2023-2033, % of Revenue 92
Figure 53. Global Addressable Market Cap in 2024-2033 by End User, Value ($ mn) and Share (%) 93
Figure 54. Global Recombinant Cell Culture Supplements Market by End User: Biopharmaceutical Companies, 2023-2033, $ mn 94
Figure 55. Global Recombinant Cell Culture Supplements Market by End User: Contract Research Centers (CROs), 2023-2033, $ mn 95
Figure 56. Global Recombinant Cell Culture Supplements Market by End User: Academic & Research Institutes, 2023-2033, $ mn 96
Figure 57. Global Market Snapshot by Region 97
Figure 58. Growth Opportunity Analysis of Global Market by Region 98
Figure 59. Geographic Spread of Worldwide Recombinant Cell Culture Supplements Market, 2023-2033, % of Sales Revenue 99
Figure 60. Global Addressable Market Cap in 2024-2033 by Region, Value ($ mn) and Share (%) 100
Figure 61. North American Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 103
Figure 62. Growth Opportunity Analysis of North America Market by Country 103
Figure 63. Breakdown of North America Recombinant Cell Culture Supplements Market by Country, 2023 and 2033, % of Revenue 104
Figure 64. Contribution to North America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 105
Figure 65. U.S. Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 107
Figure 66. Canada Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 110
Figure 67. Recombinant Cell Culture Supplements Market in Mexico, 2023-2033, $ mn 113
Figure 68. European Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 117
Figure 69. Growth Opportunity Analysis of Europe Market by Country 117
Figure 70. Breakdown of European Recombinant Cell Culture Supplements Market by Country, 2023 and 2033, % of Revenue 118
Figure 71. Contribution to Europe 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 119
Figure 72. Recombinant Cell Culture Supplements Market in Germany, 2023-2033, $ mn 120
Figure 73. Recombinant Cell Culture Supplements Market in U.K., 2023-2033, $ mn 123
Figure 74. Recombinant Cell Culture Supplements Market in France, 2023-2033, $ mn 126
Figure 75. Recombinant Cell Culture Supplements Market in Spain, 2023-2033, $ mn 129
Figure 76. Recombinant Cell Culture Supplements Market in Italy, 2023-2033, $ mn 132
Figure 77. Recombinant Cell Culture Supplements Market in Russia, 2023-2033, $ mn 135
Figure 78. Recombinant Cell Culture Supplements Market in Rest of Europe, 2023-2033, $ mn 138
Figure 79. Asia-Pacific Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 141
Figure 80. Growth Opportunity Analysis of Asia-Pacific Market by Country 141
Figure 81. Breakdown of APAC Recombinant Cell Culture Supplements Market by Country, 2023 and 2033, % of Revenue 142
Figure 82. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 143
Figure 83. Recombinant Cell Culture Supplements Market in Japan, 2023-2033, $ mn 145
Figure 84. Recombinant Cell Culture Supplements Market in China, 2023-2033, $ mn 148
Figure 85. Recombinant Cell Culture Supplements Market in Australia, 2023-2033, $ mn 151
Figure 86. Recombinant Cell Culture Supplements Market in India, 2023-2033, $ mn 154
Figure 87. Recombinant Cell Culture Supplements Market in South Korea, 2023-2033, $ mn 157
Figure 88. Recombinant Cell Culture Supplements Market in Rest of APAC, 2023-2033, $ mn 160
Figure 89. South America Recombinant Cell Culture Supplements Market, 2023-2033, $ mn 163
Figure 90. Growth Opportunity Analysis of South America Market by Country 163
Figure 91. Breakdown of South America Recombinant Cell Culture Supplements Market by Country, 2023 and 2033, % of Revenue 164
Figure 92. Contribution to South America 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 165
Figure 93. Recombinant Cell Culture Supplements Market in Argentina, 2023-2033, $ mn 166
Figure 94. Recombinant Cell Culture Supplements Market in Brazil, 2023-2033, $ mn 169
Figure 95. Recombinant Cell Culture Supplements Market in Chile, 2023-2033, $ mn 172
Figure 96. Recombinant Cell Culture Supplements Market in Rest of South America, 2023-2033, $ mn 175
Figure 97. Recombinant Cell Culture Supplements Market in Middle East and Africa (MEA), 2023-2033, $ mn 177
Figure 98. Growth Opportunity Analysis of MEA Market by Country 177
Figure 99. Breakdown of MEA Recombinant Cell Culture Supplements Market by Country, 2023 and 2033, % of Revenue 178
Figure 100. Contribution to MEA 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%) 179
Figure 101. Recombinant Cell Culture Supplements Market in UAE, 2023-2033, $ mn 180
Figure 102. Recombinant Cell Culture Supplements Market in Saudi Arabia, 2023-2033, $ mn 183
Figure 103. Recombinant Cell Culture Supplements Market in South Africa, 2023-2033, $ mn 186
Figure 104. Recombinant Cell Culture Supplements Market in the Rest of MEA, 2023-2033, $ mn 189
Figure 105. Growth Stage of Global Recombinant Cell Culture Supplements Industry over the Forecast Period 190
Figure 106. Comparison of Risk Factors by GMD RIN in 2023 218
Figure 107. GMD Relative RIN of Internal Risk Factors in 2023 on Radar Chart 219
Figure 108. GMD Relative RIN of External Risk Factors in 2023 on Radar Chart 219

Reviews

There are yet no reviews for this product.